Literature DB >> 29853572

Atrial fibrillation and stroke prevention: where we are and where we should be.

Nicholas R Jones1, Fd Richard Hobbs1, Clare J Taylor1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29853572      PMCID： PMC6001982          DOI： 10.3399/bjgp18X696257

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  7 in total

1.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Authors:  Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas
Journal:  Eur Heart J       Date:  2016-08-27       Impact factor: 29.983

2.  Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.

Authors:  Christian T Ruff; Robert P Giugliano; Eugene Braunwald; Elaine B Hoffman; Naveen Deenadayalu; Michael D Ezekowitz; A John Camm; Jeffrey I Weitz; Basil S Lewis; Alexander Parkhomenko; Takeshi Yamashita; Elliott M Antman
Journal:  Lancet       Date:  2013-12-04       Impact factor: 79.321

3.  Variation in anticoagulation for atrial fibrillation between English clinical commissioning groups: an observational study.

Authors:  John Robson; Kate Homer; Zaheer Ahmed; Sotiris Antoniou
Journal:  Br J Gen Pract       Date:  2018-07-02       Impact factor: 5.386

4.  Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis.

Authors:  Niteesh K Choudhry; Geoffrey M Anderson; Andreas Laupacis; Dennis Ross-Degnan; Sharon-Lise T Normand; Stephen B Soumerai
Journal:  BMJ       Date:  2006-01-10

5.  Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.

Authors:  Eduard Shantsila; Andreas Wolff; Gregory Y H Lip; Deirdre A Lane
Journal:  Br J Gen Pract       Date:  2015-01       Impact factor: 5.386

6.  Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.

Authors:  Jonathan Mant; F D Richard Hobbs; Kate Fletcher; Andrea Roalfe; David Fitzmaurice; Gregory Y H Lip; Ellen Murray
Journal:  Lancet       Date:  2007-08-11       Impact factor: 79.321

7.  Age-specific incidence, outcome, cost, and projected future burden of atrial fibrillation-related embolic vascular events: a population-based study.

Authors:  Gabriel S C Yiin; Dominic P J Howard; Nicola L M Paul; Linxin Li; Ramon Luengo-Fernandez; Linda M Bull; Sarah J V Welch; Sergei A Gutnikov; Ziyah Mehta; Peter M Rothwell
Journal:  Circulation       Date:  2014-09-10       Impact factor: 29.690
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.